Clinical trial
Ranibizumab in Idiopathic Parafoveal Telangiectasia (RIPT) Trial
NCT00378196 · Johns Hopkins University, Other · Completed
Key facts
| NCT number | NCT00378196 |
|---|---|
| Title | Ranibizumab in Idiopathic Parafoveal Telangiectasia (RIPT) Trial |
| Official title | Ranibizumab in Idiopathic Parafoveal Telangiectasia (RIPT) Trial |
| Lead sponsor | Johns Hopkins University, Other |
| Collaborators | Genentech, Inc. Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Telangiectasia |
| Intervention type | Drug |
| Interventions | Ranibizumab |
| Enrollment | 10 |
| Start date | Sep 1, 2006 |
| Primary completion | Sep 1, 2007 |
| Completion | Dec 1, 2008 |
| First posted | Sep 19, 2006 |
| Last update posted | Nov 14, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: